Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 2
This trial is looking at a drug called nivolumab for people with diffuse large B cell lymphoma (DLBCL). It is for people whose lymphoma has come back or is no longer responding to treatment.
Recruitment start: 1 February 2014
Recruitment end: 10 July 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Johnson
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 30 Jul 2015
CRUK internal database number: 10820
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
